Lv11
68 积分 2023-08-07 加入
Prophylaxis in children with haemophilia in an evolving treatment landscape
4小时前
已完结
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT
7天前
已完结
AB1141 THERAPEUTIC POTENTIAL OF INHIBITION OF JAK1 AND 2 BY RUXOLITINIB, OF ROCK2 BY BELUMOSUDIL, AND OF BTK BY IBRUTINIB IN SYSTEMIC SCLEROSIS
21天前
已关闭
Protective factors, management and prognosis of mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia in children
1个月前
已完结
Improved GVHD-free and relapse-free survival after ex vivo αβTCR and CD19 depleted allogeneic HSCT compared to T cell replete HSCT
1个月前
已关闭
Superior outcomes of haploidentical hematopoietic cell transplantation over chemotherapy in AML patients 55 years or older
1个月前
已完结
Pre-transplant inflammation and its associations with acute GvHD and mortality in pediatric allogeneic hematopoietic stem cell transplantation patients
1个月前
已完结
Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures
2个月前
已完结
Recent advances in surgery and its perioperative treatment in people with hemophilia
2个月前
已完结
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
2个月前
已完结
皖公网安备34019202002308
